Pharmacological modification of oxygen affinity improves deformability of deoxygenated sickle erythrocytes: a possible therapeutic approach to sickle cell disease.
about
Bone marrow transplantation in sickle cell anaemiaTechnological advances in blood rheology.New developments in anti-sickling agents: can drugs directly prevent the polymerization of sickle haemoglobin in vivo?Pharmacokinetics and pharmacodynamics of tucaresol, an antisickling agent, in healthy volunteers.The pharmacokinetics, tolerability and pharmacodynamics of tucaresol (589C80; 4[2-formyl-3-hydroxyphenoxymethyl] benzoic acid), a potential anti-sickling agent, following oral administration to healthy subjects.
P2860
Pharmacological modification of oxygen affinity improves deformability of deoxygenated sickle erythrocytes: a possible therapeutic approach to sickle cell disease.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh-hant
name
Pharmacological modification o ...... proach to sickle cell disease.
@en
Pharmacological modification o ...... proach to sickle cell disease.
@nl
type
label
Pharmacological modification o ...... proach to sickle cell disease.
@en
Pharmacological modification o ...... proach to sickle cell disease.
@nl
prefLabel
Pharmacological modification o ...... proach to sickle cell disease.
@en
Pharmacological modification o ...... proach to sickle cell disease.
@nl
P2093
P356
P1433
P1476
Pharmacological modification o ...... proach to sickle cell disease.
@en
P2093
P304
P356
10.1042/CS0760357
P407
P577
1989-04-01T00:00:00Z